Fingerprint
Dive into the research topics of 'Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically